163 related articles for article (PubMed ID: 17966185)
1. Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Sumner W; Feldman SR
J Drugs Dermatol; 2007 Oct; 6(10):1048. PubMed ID: 17966185
[TBL] [Abstract][Full Text] [Related]
2. Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis.
Huo R; Romanelli P
Am J Clin Dermatol; 2010; 11 Suppl 1():39-40. PubMed ID: 20586506
[TBL] [Abstract][Full Text] [Related]
3. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
[TBL] [Abstract][Full Text] [Related]
4. Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report.
Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Tolino E; Zuber S; Potenza C
Cutis; 2012 Sep; 90(3):120-2. PubMed ID: 23094309
[TBL] [Abstract][Full Text] [Related]
5. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
[TBL] [Abstract][Full Text] [Related]
6. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
De Simone C; Carbone A; Caldarola G
Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.
Perlmutter A; Mittal A; Menter A
Br J Dermatol; 2009 Jan; 160(1):8-15. PubMed ID: 19016693
[TBL] [Abstract][Full Text] [Related]
8. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
[No Abstract] [Full Text] [Related]
9. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
Desai N; Raste Y; Cooke NT; Harland CC
Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
[No Abstract] [Full Text] [Related]
10. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
Cecchi R; Bartoli L
Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
[TBL] [Abstract][Full Text] [Related]
11. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
Prestinari F; Ferguglia G; Laria G
Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
13. [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF-alpha inhibitors in psoriasis patients].
Goujon C; Gormand F; Gunera-Saad N; Dahel K; Vial T; Nicolas JF
Ann Dermatol Venereol; 2010; 137(6-7):437-43. PubMed ID: 20620572
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade.
Wallis RS
Arthritis Rheum; 2008 Apr; 58(4):947-52. PubMed ID: 18383389
[TBL] [Abstract][Full Text] [Related]
15. Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept?
Ahmad K; McDonnell TJ; Rogers S
Clin Exp Dermatol; 2007 May; 32(3):329. PubMed ID: 17397361
[No Abstract] [Full Text] [Related]
16. Localized cutaneous Cryptococcus albidus infection in a 14-year-old boy on etanercept therapy.
Hoang JK; Burruss J
Pediatr Dermatol; 2007; 24(3):285-8. PubMed ID: 17542882
[TBL] [Abstract][Full Text] [Related]
17. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
[No Abstract] [Full Text] [Related]
18. Facial granulomatous nodules during etanercept treatment for psoriasis.
Samimi M; Lorette G; Machet L; de Muret A; Watier H; Maruani A
Int J Dermatol; 2009 Sep; 48(9):1025-7. PubMed ID: 19703000
[No Abstract] [Full Text] [Related]
19. [Episode of pustular psoriasis after a tuberculin test in a patient with plaque psoriasis on treatment with etanercept].
Guinovart RM; Ferrándiz C; Bielsa I; Carrascosa JM
Actas Dermosifiliogr; 2011 Dec; 102(10):828-30. PubMed ID: 21798486
[No Abstract] [Full Text] [Related]
20. Tuberculosis in the age of biologic therapy.
Hernandez C; Cetner AS; Jordan JE; Puangsuvan SN; Robinson JK
J Am Acad Dermatol; 2008 Sep; 59(3):363-80; quiz 382-4. PubMed ID: 18694676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]